Daniel Bürgisser

Using nature’s blueprint to expand catalysis with Earth-abundant metals

End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design

Mutants of human insulin-like growth factor II: Expression and characterization of analogs with a substitution of Tyr27 and/or a deletion of residues 62–67

Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor.